His research combines pathway analysis tools and novel multiplex assays for early drug discovery. Dr Alexopoulos received his PhD from the department of Biomedical Engineering at Duke University in 2004 and subsequently he attended MIT (Dept of Biological Eng) and Harvard Medical School (Dept of Systems Biology) for his postdoctoral research. He has strong publication record and he collaborates with major pharmaceutical companies including Roche, Becton & Dickinson, Vertex, Pfizer, and Boehringer-Ingelheim in the area of systems biology for drug discovery.